Hem › Juvenil artrit › District of Columbia
Kliniska studier för Juvenil artrit i District of Columbia
4 studier för Juvenil artrit söker deltagare vid platser i District of Columbia.
Städer i District of Columbia
Officiell studietext (engelska)
Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active Systemic Juvenile Idiopathic Arthritis.
- Childrens National Medical Center /ID# 253344, Washington D.C.
RekryterarFas 3
Ålder 1 till 17 · Alla kön · Uppdaterad 15 sep. 2026 · NCT05609630A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
- Childrens National Medical Center /ID# 259284, Washington D.C.
RekryterarFas 3
Ålder 5 till 17 · Alla kön · Uppdaterad 1 sep. 2026 · NCT06100744Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
- Childrens National Medical Center, Washington D.C.
RekryterarObservationsstudie
Upp till ålder 21 · Alla kön · Uppdaterad 27 aug. 2026 · NCT02418442Development of a Therapeutic Endpoint in Pediatric Rheumatologic Conditions
- Children's National Health System, Washington D.C.
RekryterarObservationsstudie
Ålder 5 till 21 · Alla kön · Uppdaterad 24 juli 2026 · NCT04833465Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.